Brain cholesterol and suicidal behaviour

International Journal of Neuropsychopharmacology

Volumn 10, Issue 2, 2007, Pages 153-157

  Lütjohann, Dieter ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DESMOSTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LANOSTEROL; LATHOSTEROL;

AGING; AMYGDALOID NUCLEUS; ATHEROSCLEROSIS; BIPOLAR DISORDER; BLOOD BRAIN BARRIER; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; FETUS DEATH; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; LIPOPROTEIN METABOLISM; MAJOR DEPRESSION; MOOD DISORDER; NEWBORN DEATH; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SMITH LEMLI OPITZ SYNDROME; SUICIDAL BEHAVIOR; UPREGULATION;

ANIMALS; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM; CHOLESTEROL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MICE; MOOD DISORDERS; SUICIDE;

EID: 33847032973     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706007048     Document Type: Review

References (58)

1. Alvarez JC, Cremniter D, Gluck N, Quintin P, Leboyer M, Berlin I, Therond P, Spreux-Varoquaux O (2000). Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Research 95, 103-108.
2. Andersen JM, Dietschy JM (1977). Regulation of sterol synthesis in 15 tissues of rat. II. Role of rat and human high and low density plasma lipoproteins and of rat chylomicron remnants. Journal of Biological Chemistry 252, 3652-3659.
3. Bennion LJ, Grundy SM (1978a). Risk factors for the development of cholelithiasis in man. New England Journal of Medicine 299, 1161-1167.
4. Bennion LJ, Grundy SM (1978b). Risk factors for the development of cholelithiasis in man. New England Journal of Medicine 299, 1221-1227.
5. Björkhem I, Lütjohann D, Breuer O, Sakinis A, Wennmalm A (1997). Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. Journal of Biological Chemistry 272, 30178-30184.
6. Björkhem I, Lütjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J (1998). Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. Journal of Lipid Research 39, 1594-1600.
7. Boston PF, Dursun SM, Reveley MA (1994). Cholesterol and violent death. Other studies exist. British Medical Journal 309, 1228.
8. Boston PF, Dursun SM, Zafar R, Reveley MA (1996). Serum cholesterol and treatment-resistance in schizophrenia. Biological Psychiatry 40, 542-543.
9. Bourre JM, Clement M, Gerard D, Legran R, Chaudiere J (1990). Precursors for cholesterol synthesis (7-dehydrocholesterol, 7- dehydrodesmosterol, and desmosterol): cholesterol/7-dehydrocholesterol ratio as an index of development and aging in PNS but not in CNS. Journal of Neurochemistry 54, 1196-1199.
10. Brown MS, Goldstein JL (1986). A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47.
11. Clayton P, Mills K, Keeling J, FitzPatrick D (1996). Desmosterolosis: a new inborn error of cholesterol biosynthesis [Letter ; Comment]. Lancet 348, 404.
12. Dehouck B, Dehouck MP, Fruchart JC, Cecchelli R (1994). Upregulation of the low density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. Journal of Cell Biology 126, 465-473.
13. Dietschy JM, Kita T, Sucklung KE, Goldstein JL, Brown MS (1983). Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors. Journal of Lipid Research 24, 469-480.
14. Dietschy JM, Turley SD (2001). Cholesterol metabolism in the brain. Current Opinion in Lipidology 12, 105-112.
15. Dietschy JM, Turley SD, Spady DK (1993). Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. Journal of Lipid Research 34, 1637-1659.
16. Edmond J, Korsak RA, Morrow JW, Torok Both G, Catlin DH (1991). Dietary cholesterol and the origin of cholesterol in the brain of developing rats. Journal of Nutrition 121, 1323-1330.
17. Grundy SM (1993). Oxidized LDL and atherogenesis: relation to risk factors for coronary heart disease. Clinical Cardiology 16, I3-5.
18. Grundy SM, Cleeman JI, Merz CN, Brewer Jr. HB, Clark LT, Hunninghake DB, Pasternak RC, Smith Jr. SC, Stone NJ (2004). Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Journal of the American College of Cardiology 44, 720-732.
19. Hobbs HH, Brown MS, Goldstein JL (1992). Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Human Mutation 1, 445-466.
20. Hoffmann GF, Charpentier C, Mayatepek E, Mancini J, Leichsenring M, Gibson KM, Divry P, Hrebicek M, Lehnert W, Sartor K, et al. (1993). Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 91, 915-921.
21. Iribarren C, Reed DM, Wergowske G, Burchfiel CM, Dwyer JH (1995). Serum cholesterol level and mortality due to suicide and trauma in the Honolulu Heart Program. Archives of Internal Medicine 155, 695-700.
22. Irons M, Elias ER, Salen G, Tint GS, Batta AK (1993). Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome [Letter]. Lancet 341, 1414.
23. Johnson-Anuna LN, Eckert GP, Keller JH, Igbavboa U, Franke C, Fechner T, Schubert-Zsilavecz M, Karas M, Muller WE, Wood WG (2005). Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex. Journal of Pharmacology and Experimental Therapeutics 312, 786-793.
24. King DS, Wilburn AJ, Wofford MR, Harrell TK, Lindley BJ, Jones DW (2003). Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 23, 1663-1667.
25. Kunugi H, Takei N, Aoki H, Nanko S (1997). Low serum cholesterol in suicide attempters. Biological Psychiatry 41, 196-200.
26. Lalovic A, Levy E, Luheshi G, Canetti L, Grenier E, Sequeira A, Turecki G (2006). Cholesterol content in brains of suicide completers. International Journal of Neuropsychopharmacology. Published online: 17 May 2006. doi:10.1017/S1461145706006663.
27. Lalovic A, Merkens L, Russell L, Arsenault-Lapierre G, Nowaczyk MJ, Porter FD, Steiner RD, Turecki G (2004). Cholesterol metabolism and suicidality in Smith-Lemli-Opitz syndrome carriers. American Journal of Psychiatry 161, 2123-2126.
28. Langan TJ, Iimori Y, White G, Volpe JJ (1987). Regulation of sterol synthesis and of 3-hydroxy-3-methylglutaryl coenzyme A reductase by lipoproteins in glial cells in primary culture. Journal of Neuroscience Research 17, 361-366.
29. Lin DS, Connor WE (1980). The long term effects of dietary cholesterol upon the plasma lipids, lipoproteins, cholesterol absorption, and the sterol balance in man: the demonstration of feedback inhibition of cholesterol biosynthesis and increased bile acid excretion. Journal of Lipid Research 21, 1042-1052.
30. Lütjohann D, Breuer O, Ahlborg G, Nennesmo I, Siden A, Diczfalusy U, Björkhem I (1996). Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proceedings of the National Academy of Sciences USA 93, 9799-9804.
31. Marcinko D, Martinac M, Karlovic D, Filipcic I, Loncar C, Pivac N, Jakovljevic M (2005). Are there differences in serum cholesterol and cortisol concentrations between violent and non-violent schizophrenic male suicide attempters? Collegium Antropologicum 29, 153-157.
32. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW (2001). CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354-1357.
33. Modai I, Valevski A, Dror S, Weizman A (1994). Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. Journal of Clinical Psychiatry 55, 252-254.
34. Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL (1993). Plasma cholesterol and depressive symptoms in older men. Lancet 341, 75-79.
35. Motulsky AG (1986). The 1985 Nobel Prize in physiology or medicine. Science 231, 126-129.
36. Osono Y, Wollett LA, Herz J, Dietschey JM (1995). Role of the low density lipoprotein receptor in the flux of cholesterol through the plasma and across the tissues of the mouse. Journal of Clinical Investigation 95, 1124-1132.
37. Palinkas LA, Barrett-Connor E, Morgan RE, Wingard DL (1993). Serum lipids and depression. Lancet 341, 563.
38. Panzenboeck U, Balazs Z, Sovic A, Hrzenjak A, Levak-Frank S, Wintersperger A, Malle E, Sattler W (2002). ABCA1, and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. Journal of Biological Chemistry 277, 42781-42789.
39. Papassotiropoulos A, Hawellek B, Frahnert C, Rao GS, Rao ML (1999). The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry 32, 1-4.
40. Partonen T, Haukka J, Virtamo J, Taylor PR, Lonnqvist J (1999). Association of low serum total cholesterol with major depression and suicide. British Journal of Psychiatry 175, 259-262.
41. Pfrieger F (2002). Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes. BioEssays 25, 72-76.
42. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW (1987). Astrocytes synthesize apolipoprotein E and metabolize apolipoproteine E-containing lipoproteins. Biochimica et Biophysica Acta 917, 148-161.
43. Plotz EJ, Kabara JJ, Davis ME, LeRoy GV, Gould RG (1968). Studies on the synthesis of cholesterol in the brain of the human fetus. American Journal of Obstetrics and Gynecology 101, 534-538.
44. Repa JJ, Mangelsdorf DJ (2000). The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annual Review of Cell and Developmental Biology 16, 459-481.
45. Sarchiapone M, Camardese G, Roy A, Della Casa S, Satta MA, Gonzalez B, Berman J, De Risio S (2001). Cholesterol and serotonin indices in depressed and suicidal patients. Journal of Affective Disorders 62, 217-219.
46. Snipes GJ, Suter U (1997). Cholesterol and myelin. In: Bittman R (Ed.), Subcellular Biochemistry (pp. 173-204). New York: Plenum Press.
47. Spady DK, Dietschy JM (1983). Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. Journal of Lipid Research 24, 303-315.
48. Spady DK, Huettinger M, Bilheimer DW, Dietschy JM (1987). Role of receptor-independent low density lipoprotein transport in the maintenance of tissue cholesterol balance in the normal and WHHL rabbit. Journal of Lipid Research 28, 32-41.
49. Tanskanen A, Vartiainen E, Tuomilehto J, Viinamaki H, Lehtonen J, Puska P (2000). High serum cholesterol and risk of suicide. American Journal of Psychiatry 157, 648-650.
50. Thelen KM, Falkai P, Bayer TA, Lütjohann D (2006). Cholesterol synthesis rate in human hippocampus declines with aging. Neuroscience Letters. Published online: 15 May 2006. doi:10.1016/J. neulet.2006.040.034.
51. Thelen KM, Rentsch KM, Gutteck U, Heverin M, Olin M, Andersson U, von Eckardstein A, Björkhem I, Lütjohann D (2005). Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. Journal of Pharmacology and Experimental Therapeutics 316, 1146-1152.
52. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G (1994). Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. New England Journal of Medicine 330, 107-113.
53. Vartiainen E, Puska P, Pekkanen J, Tuomilehto J, Lonnqvist J, Ehnholm C (1994). Serum cholesterol concentration and mortality from accidents, suicide, and other violent causes. British Medical Journal 309, 445-447.
54. Vevera J, Zukov I, Morcinek T, Papezova H (2003). Cholesterol concentrations in violent and nonviolent women suicide attempters. European Psychiatry 18, 23-27.
55. Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy PM (2003). Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 23, 871-880.
56. Wang L, Schuster GU, Hultenby K, Zhang Q, Andersson S, Gustafsson JA (2002). Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proceedings of the National Academy of Sciences USA 99, 13878-13883.
57. Whitney KD, Watson MA, Collins JL, Benson WG, Stone TM, Numerick MJ, Tippin TK, Wilson JG, Winegar DA, Kliewer SA (2002). Regulation of cholesterol homeostasis by the liver x receptors in the central nervous system. Molecular Endocrinology 16, 1378-1385.
58. Yeagle PL (1985). Cholesterol and the cell membrane. Biochimica et Biophysica Acta 822, 267-287.